The store will not work correctly when cookies are disabled.
Ethyl 5-amino-2-methyl-[1,2,4]triazolo[1,5-c]pyrimidine-8-carboxylate
ID: ALA4790041
PubChem CID: 162669857
Max Phase: Preclinical
Molecular Formula: C9H11N5O2
Molecular Weight: 221.22
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cnc(N)n2nc(C)nc12
Standard InChI: InChI=1S/C9H11N5O2/c1-3-16-8(15)6-4-11-9(10)14-7(6)12-5(2)13-14/h4H,3H2,1-2H3,(H2,10,11)
Standard InChI Key: NCJYSJOUGQNVSI-UHFFFAOYSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
1.2569 -2.4749 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2558 -3.3023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9705 -3.7151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9687 -2.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6840 -2.4712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6889 -3.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4764 -3.5485 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9583 -2.8771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4685 -2.2114 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9663 -1.2372 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9716 -4.5400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2577 -4.9534 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6866 -4.9516 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4005 -4.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1154 -4.9498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7832 -2.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
3 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 1 0
8 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 221.22 | Molecular Weight (Monoisotopic): 221.0913 | AlogP: 0.19 | #Rotatable Bonds: 2 |
Polar Surface Area: 95.40 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.75 | CX LogP: 0.93 | CX LogD: 0.93 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.73 | Np Likeness Score: -1.66 |
References
1. Grieco I,Bissaro M,Tiz DB,Perez DI,Perez C,Martinez A,Redenti S,Mariotto E,Bortolozzi R,Viola G,Cozza G,Spalluto G,Moro S,Federico S. (2021) Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems., 216 [PMID:33721670] [10.1016/j.ejmech.2021.113331] |